- Home
- ASC vs KMDA Comparison
ASC vs KMDA Comparison
Compare ASC & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASC
- KMDA
- Stock Information
- Founded
- ASC 2010
- KMDA 1990
- Country
- ASC Bermuda
- KMDA Israel
- Employees
- ASC N/A
- KMDA N/A
- Industry
- ASC Marine Transportation
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- ASC Consumer Discretionary
- KMDA Health Care
- Exchange
- ASC Nasdaq
- KMDA Nasdaq
- Market Cap
- ASC 399.7M
- KMDA 430.1M
- IPO Year
- ASC 2013
- KMDA N/A
- Fundamental
- Price
- ASC $10.65
- KMDA $7.35
- Analyst Decision
- ASC Buy
- KMDA Strong Buy
- Analyst Count
- ASC 3
- KMDA 2
- Target Price
- ASC $12.67
- KMDA $13.00
- AVG Volume (30 Days)
- ASC 603.2K
- KMDA 49.4K
- Earning Date
- ASC 07-30-2025
- KMDA 08-13-2025
- Dividend Yield
- ASC 8.92%
- KMDA 2.72%
- EPS Growth
- ASC N/A
- KMDA 27.97
- EPS
- ASC 1.04
- KMDA 0.32
- Revenue
- ASC $324,200,000.00
- KMDA $169,517,000.00
- Revenue This Year
- ASC N/A
- KMDA $14.51
- Revenue Next Year
- ASC N/A
- KMDA $9.31
- P/E Ratio
- ASC $10.11
- KMDA $22.26
- Revenue Growth
- ASC N/A
- KMDA 9.67
- 52 Week Low
- ASC $8.32
- KMDA $5.17
- 52 Week High
- ASC $20.17
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- ASC 53.93
- KMDA 48.99
- Support Level
- ASC $10.17
- KMDA $7.15
- Resistance Level
- ASC $10.65
- KMDA $7.85
- Average True Range (ATR)
- ASC 0.43
- KMDA 0.22
- MACD
- ASC -0.04
- KMDA 0.00
- Stochastic Oscillator
- ASC 39.67
- KMDA 54.13
About ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.